Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)
11.64
+0.05 (0.43%)
At close: Feb 27, 2026
SHA:603811 Market Cap
SHA:603811 has a market cap or net worth of 3.7 billion as of February 27, 2026. Its market cap has increased by 44.29% in one year.
Market Cap
3.70B
Enterprise Value
3.62B
Revenue
790.86M
Ranking
n/a
PE Ratio
16.61
Stock Price
11.64
Market Cap Chart
Since March 15, 2017, SHA:603811's market cap has increased from 1.93B to 3.70B, an increase of 91.28%. That is a compound annual growth rate of 7.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.70B | 10.86% |
| Dec 31, 2025 | 3.34B | 32.01% |
| Dec 31, 2024 | 2.53B | -25.55% |
| Dec 29, 2023 | 3.39B | 3.77% |
| Dec 30, 2022 | 3.27B | -13.80% |
| Dec 31, 2021 | 3.79B | -1.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Huaren Pharmaceutical | 3.87B |
| Harbin Medisan Pharmaceutical | 3.82B |
| Nanjing Well Pharmaceutical Group | 3.77B |
| Hunan Hansen Pharmaceutical | 3.76B |
| PKU HealthCare Corp.,Ltd. | 3.74B |
| Anhui Sunhere Pharmaceutical Excipients | 3.72B |
| Tuoxin Pharmaceutical Group | 3.71B |
| Zhejiang Shengda Bio-Pharm | 3.67B |